Offer - Urjas Oil for just ₹ 1
Telmivas 20 Tablet is a prescription drug, available for use as Tablet. It is typically used for the treatment of High BP, Heart Failure, High BP. Secondary and off-label uses of Telmivas 20 Tablet have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Telmivas 20 Tablet. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
The side effects typically associated with Telmivas 20 Tablet include Back Pain. While these are the most often observed Telmivas 20 Tablet side effects, there are can be others also. These have been listed below. These side effects of Telmivas 20 Tablet are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
Telmivas 20 Tablet's effect during pregnancy is Safe and Safe while nursing. It is important to know if Telmivas 20 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Telmivas 20 Tablet related warnings section.
Telmivas 20 Tablet is contraindicated in people with pre-existing medical conditions like Low Blood Pressure (Hypotension), Coronary Artery Disease (CAD), Liver Disease as it can result in adverse effects. The section on Telmivas 20 Tablet contraindications lists all such conditions.
Besides this, Telmivas 20 Tablet may also have severe interaction with some medicines. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Telmivas 20 Tablet is considered not safe while driving, and is not addictive.
Telmivas 20 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Telmivas 20 Tablet safe for pregnant women?
Telmivas can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Telmivas 20 Tablet safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Telmivas. It should only be taken after medical advice.
What is the effect of Telmivas 20 Tablet on the Kidneys?
Telmivas rarely harms the kidneys.
What is the effect of Telmivas 20 Tablet on the Liver?
Telmivas is rarely harmful for the liver.
What is the effect of Telmivas 20 Tablet on the Heart?
Side effects of Telmivas rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Telmivas 20 Tablet unless your doctor advises you to do so -
Is this Telmivas 20 Tablet habit forming or addictive?
No, you will not get addicted to Telmivas 20 Tablet.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Telmivas 20 Tablet as you may feel sleepy.
Is it safe?
Yes, Telmivas 20 Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Telmivas 20 Tablet for mental disorders.
Interaction between Food and Telmivas 20 Tablet
Due to the absence of research, it is difficult to say how Telmivas 20 Tablet and food will interact.
Interaction between Alcohol and Telmivas 20 Tablet
Consumption of alcohol and Telmivas 20 Tablet together may have severe effects on your health.
Yes, Telmivas can be taken with ibuprofen. No harmful drug interaction has been reported between them. However, if you feel any discomfort after taking ibuprofen do not hesitate to inform your doctor.
Yes, [medicine] can cause stomach upset. It is a common side effect of this drug. Please inform your doctor if you are experiencing stomach upset after taking this medicine.
Telmivas comes in form of a tablet and ideally, it should be taken by mouth once daily as advised by your doctor. It can be taken with food or without food at any time of the day. Precautions must be taken in patients with liver disease, diabetes, and hypothyroidism.
Telmivas is calcium channel blocker. It works by inhibiting the movement of calcium into vascular smooth muscle cells and cardiac cells which inhibits the contraction of cardiac muscle and vascular smooth muscle and reduce electrical conduction within heart cell and dilate blood vessel. Dilation of the blood vessel reduces the blood pressure.
No, Telmivas should not be discontinued on your own. Discontinuation of a drug on your own can cause some serious problem such as blood pressure or chest pain which lead to heart attack and stroke. So before stopping this medicine, you must consult your doctor, he/she may switch your treatment if you can not tolerate this drug.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvasc® (amlodipine besylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 540, 549, 550
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 147-148
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hydrochlorothiazide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 582-586
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448